This is a Validated Antibody Database (VAD) review about human SRSF7, based on 3 published articles (read how Labome selects the articles), using SRSF7 antibody in all methods. It is aimed to help Labome visitors find the most suited SRSF7 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
SRSF7 synonym: 9G8; AAG3; SFRS7; serine/arginine-rich splicing factor 7; SR splicing factor 7; aging-associated protein 3; splicing factor 9G8; splicing factor, arginine/serine-rich 7, 35kDa
Proteintech Group
rabbit polyclonal |
| In order to report the interactome of all dipeptide repeat proteins, Proteintech Group SRSF7 antibody (Proteintech, 11044-1-AP) was used in western blot on human samples (fig 1c). Cell (2016) ncbi |
Abcam
rabbit polyclonal |
| In order to characterize the involvement of concerted non-productive splicing of post-transcriptional regulators that involves the alternative splicing program of differentiatied smooth muscle cells, Abcam SRSF7 antibody (Abcam, ab138022) was used in western blot on mouse samples (fig 7). Nucleic Acids Res (2016) ncbi |
Sigma-Aldrich
rabbit polyclonal |
| In order to compare colorectal and gastric cancer and their expression patterns and diagnostic efficacies of SR splicing factors and HNRNPA1, Sigma-Aldrich SRSF7 antibody (Sigma-Aldrich, HPA043850) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 1) and in western blot on human samples at 1:1000 (fig 1). BMC Cancer (2016) ncbi |
Articles Reviewed
- Llorian M, Gooding C, Bellora N, Hallegger M, Buckroyd A, Wang X, et al. The alternative splicing program of differentiated smooth muscle cells involves concerted non-productive splicing of post-transcriptional regulators. Nucleic Acids Res. 2016;44:8933-8950 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments